Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - SPIRE HEALTHCARE GROUP PLC

26th Oct 2017 10:46

RNS Number : 7116U
Nomura International PLC
26 October 2017
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Nomura International PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

NA

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Spire Healthcare Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

NA

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25 Oct 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, Mediclinic International Plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

9,218,022

2.298

3,933,692

0.981

(2) Cash-settled derivatives:

 

3,933,692

0.981

9,218,022

2.298

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.000

0

0.000

 

TOTAL:

13,151,714

3.279

13,151,714

3.279

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary Shares

Purchase

62,000

3.0069

Ordinary Shares

Purchase

4,560

3.0114

Ordinary Shares

Purchase

8,285

3.0136

Ordinary Shares

Purchase

10,000

3.0157

Ordinary Shares

Purchase

115,177

3.0185

Ordinary Shares

Purchase

2,601

3.0241

Ordinary Shares

Purchase

21,351

3.0263

Ordinary Shares

Sale

40,000

3.0018

Ordinary Shares

Sale

12,417

3.0072

Ordinary Shares

Sale

50,719

3.0216

Ordinary Shares

Sale

20,833

3.0248

Ordinary Shares

Sale

3,467

3.0258

Ordinary Shares

Sale

71

3.0283

Ordinary Shares

Sale

132,000

3.0284

Ordinary Shares

Sale

5,744

3.0352

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary Shares

SWAP

Long

2,675,000

2.9920

Ordinary Shares

SWAP

Long

40,000

3.0020

Ordinary Shares

SWAP

Long

12,417

3.0072

Ordinary Shares

SWAP

Long

50,719

3.0216

Ordinary Shares

SWAP

Long

20,833

3.0251

Ordinary Shares

SWAP

Long

3,467

3.0260

Ordinary Shares

SWAP

Long

132,000

3.0289

Ordinary Shares

SWAP

Long

71

3.0290

Ordinary Shares

SWAP

Long

5,744

3.0355

Ordinary Shares

SWAP

Short

2,675,000

2.9920

Ordinary Shares

SWAP

Short

62,000

3.0066

Ordinary Shares

SWAP

Short

4,560

3.0111

Ordinary Shares

SWAP

Short

8,285

3.0134

Ordinary Shares

SWAP

Short

10,000

3.0157

Ordinary Shares

SWAP

Short

115,177

3.0185

Ordinary Shares

SWAP

Short

2,601

3.0238

Ordinary Shares

SWAP

Short

21,351

3.0260

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

26 October 2017

Contact name:

Kyere Tabiri

Telephone number:

020 7102 1267

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETFELSUMFWSELS

Related Shares:

Spire Healthcare
FTSE 100 Latest
Value8,275.66
Change0.00